Utilization of Small Changes in Serum Creatinine with Clinical Risk Factors to Assess the Risk of AKI in Critically lll Adults
Author(s) -
Din. Cruz,
Asuncion FerrerNadal,
Pasquale Piccinni,
Stuart L. Goldstein,
Lakhmir S. Chawla,
Elisa Alessandri,
Clara Belluomo Anello,
Will Bohan,
Tiziana Bove,
Nicola Brienza,
Mauro Carlini,
Francesco Forfori,
Francesco Garzotto,
Silvia Gramaticopolo,
Michele Iannuzzi,
Luca Montini,
P Pelaia,
Claudio Ronco
Publication year - 2014
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.05190513
Subject(s) - medicine , creatinine , acute kidney injury , hazard ratio , context (archaeology) , intensive care unit , clinical endpoint , intensive care medicine , renal function , kidney disease , prospective cohort study , confidence interval , clinical trial , paleontology , biology
Disease biomarkers require appropriate clinical context to be used effectively. Combining clinical risk factors, in addition to small changes in serum creatinine, has been proposed to improve the assessment of AKI. This notion was developed in order to identify the risk of AKI early in a patient's clinical course. We set out to assess the performance of this combination approach.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom